From therapeutic promise to evidentiary discipline: Reassessing MDMA‐assisted psychotherapy for posttraumatic stress disorder
Journal of Traumatic Stress · 2026-06 · 39 (3) · 601-603
DOI: 10.1002/jts.70094 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Traumatic Stress, online erschienen am 24.05.2026. Verfasst von Kadek Suhardita und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Guidance and Counseling, Universitas PGRI Mahadewa Indonesia, Denpasar, Bali, Indonesia. Hauptthemen laut MEDLINE: Stress Disorders, Post-Traumatic, N-Methyl-3,4-methylenedioxyamphetamine, Psychotherapy. Die Arbeit nennt 9 Literaturangaben.
Abstract (Originalsprache)
In this commentary on Morland et al. (2026)’s recent State of the Science article on 3,4‐methylenedioxymethamphetamine (MDMA)–assisted psychotherapy for posttraumatic stress disorder (PTSD), we aim to emphasize both MDMA's therapeutic promise and its unresolved scientific challenges. Although recent trials on MDMA‐assisted interventions have reported encouraging reductions in PTSD symptoms, the current evidence base remains constrained by several major limitations, including difficulties in blinding, expectancy effects, the absence of robust active comparator conditions, limited mechanistic clarity, and concerns regarding safety monitoring and sample generalizability. This letter argues that these issues are not peripheral but central to the interpretation and future translation of MDMA‐assisted psychotherapy. It further highlights the need to move beyond symptom reduction as the primary outcome and incorporate broader indicators of recovery, such as functioning, quality of life, relational restoration, and long‐term durability of treatment gains. In addition, we call for stronger attention to equity, scalability, therapist training, and ethical safeguards, particularly if MDMA‐assisted psychotherapy is to be considered within a global mental health framework. The discussion aims to stimulate deeper debate on how innovation in trauma treatment should be evaluated before widespread clinical adoption.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Guidance and Counseling, Universitas PGRI Mahadewa Indonesia, Denpasar, Bali, Indonesia.
- Department of Guidance and Counseling, Universitas Indraprasta PGRI, South Jakarta, Jakarta, Indonesia.
- Department of Guidance and Counseling, Universitas Islam Negeri Raden Fatah Palembang, Palembang City, South Sumatra, Indonesia.
- Department of Guidance and Counseling, Universitas Ma'arif Lampung, Metro City, Lampung, Indonesia.
- Department of Guidance and Counseling, Universitas Muria Kudus, Central Java, Indonesia.
Zitieren
APA
Suhardita, K., Krisnanda, V. D., Saputra, R., Saputra, A. A., & Kusmanto, A. S. (2026). From therapeutic promise to evidentiary discipline: Reassessing MDMA‐assisted psychotherapy for posttraumatic stress disorder. Journal of Traumatic Stress, 39(3), 601-603. https://doi.org/10.1002/jts.70094
Vancouver
Suhardita K, Krisnanda VD, Saputra R, Saputra AA, Kusmanto AS. From therapeutic promise to evidentiary discipline: Reassessing MDMA‐assisted psychotherapy for posttraumatic stress disorder. Journal of Traumatic Stress. 2026;39(3):601-603. doi:10.1002/jts.70094
BibTeX
@article{Suhardita2026,
author = {Suhardita, Kadek and Krisnanda, Veno Dwi and Saputra, Rikas and Saputra, Andika Ari and Kusmanto, Agung Slamet},
title = {From therapeutic promise to evidentiary discipline: Reassessing MDMA‐assisted psychotherapy for posttraumatic stress disorder},
journal = {Journal of Traumatic Stress},
year = {2026},
volume = {39},
number = {3},
pages = {601--603},
doi = {10.1002/jts.70094}
}
EUVIMED